PURCHASE ORDER
Active75D30126P21602
Department of Health and Human Services › Centers for Disease Control and Prevention › CDC OFFICE OF ACQUISITION SERVICES
$215.7K
obligated · signed 2 months ago
EMERGENT DRUG PANEL-V2 KITS AND LABORATORY SUPPORT SERVICES EO 14398
Performance timeline
Start
Sep 30, 2026
Current end
Sep 29, 2027
Potential end
Sep 29, 2030
with all options
Loading status
Estimated start: Sep 29, 2029
CAYMAN CHEMICAL CO INC
Contract 75D30126P21602
UEI
T1ZHJRGR7TF4
Parent Company
CAYMAN CHEMICAL CO INC
Capabilities & Certifications
Headquarters Location
Congressional District: 06
Current Obligation
$215,650
Base + Exercised Options
$215,650
Total Ceiling Value
$349,150
Contract Type
FIRM FIXED PRICE
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier agency
Centers for Disease Control and Prevention
Sub-tier agency
CDC OFFICE OF ACQUISITION SERVICES
Office
Funding Agency
Top-tier agency
Centers for Disease Control and Prevention
Sub-tier agency
CDC OFFICE OF ACQUISITION SERVICES
Office
Solicitation procedures, competition exceptions, labor standards and account totals.